跳至主要内容
临床试验/NCT05267301
NCT05267301已完成4 期

Open Label Post-market Evaluation of Orally Dosed AlmegaPL on Cholesterol and Cardio-metabolic Parameters.

Qualitas Health4 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2022年5月11日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
250
试验地点
4
主要终点
Triglyceride change from baseline

研究概览

简要总结

The aim of this study is to assess the effectiveness of Almega PL, a Nannochloropsis algae-derived extract rich in eicosapentaenoic acid (EPA), on improving blood markers associated with heart health of iwi customers.

详细描述

The investigational product iwi/Cholesterol is a commercially available capsule-form herbal (algae) supplement containing Almega®PL, a Nannochloropsis algae-derived extract rich in eicosapentaenoic acid (EPA). EPA is a type of omega-3 essential fatty acid known to play a beneficial role in protection against cardiovascular disease.The aim of this study is to assess the effectiveness of AlmegaPL on improving blood markers associated with heart health of iwi customers.The study will involve over 200 male and female new consumers of this product and monitor their blood markers during 6 months of supplementation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New iwi/AlmegaPL subscribers.

排除标准

  • Participants that are already taking AlmegaPL.
  • Participants with serious conditions including but not limited to kidney, neurological, immunological, liver and gastrointestinal disease, any heart condition or diabetes).
  • Any participant attempting conception, pregnant or breastfeeding

结局指标

主要结局

Triglyceride change from baseline

时间窗: From Baseline to Month 6

Fasting triglycerides is measured using Imaware at home cardiovascular test kit

次要结局

  • Total Cholesterol change from baseline(From Baseline to Month 6)
  • LDL-cholesterol change from Baseline(From Baseline to Month 6)
  • HDL-cholesterol change from Baseline(From Baseline to Month 6)
  • Fasting glucose(From Baseline to Month 6)
  • VLDL-Cholesterol change from Baseline(From Baseline to Month 6)
  • hs-CRP change from baseline(From Baseline to Month 6)
  • HbA1c change from Baseline(From Baseline to Month 6)

研究者

发起方
Qualitas Health
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

AlmegaPL CV Health Open Label Study | 临床试验